Vision and quality-of-life.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Transactions of the American Ophthalmological Society

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 10703139PMCID PMC1298275
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Diabetic retinopathy].

  2001cited by this paper
• Converting visual acuity to utilities.

  2000cited by this paper
• Evidence-based medicine, utilities, and quality of life.

  1999cited by this paper
• Utility values and diabetic retinopathy.

  1999cited by this paper
• Visual function among corneal disease patients waiting for penetrating keratoplasty in British Columbia.

  1998cited by this paper
• Glaucoma's impact on quality of life and its relation to clinical indicators. A pilot study.

  1998cited by this paper
• Health values of hospitalized patients 80 years or older. HELP Investigators. Hospitalized Elderly Longitudinal Project.

  1998cited by this paper
• Photorefractive keratectomy versus laser in situ keratomileusis for moderate to high myopia. A randomized prospective study.

  1998cited by this paper
• The Effect of Search Procedures on Utility Elicitations

  1998cited by this paper
• Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons.

  1998cited by this paper
• Reliable and accessible reviews of the evidence for the effect of health care: the role of the Cochrane Collaboration and the CONSORT statement

  1998cited by this paper
• Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.

  1998cited by this paper
• The Cochrane Collaboration-Advances and Challenges in Improving Evidence-based Decision Making

  1998cited by this paper
• Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group.

  1997cited by this paper
• Influence of glaucomatous visual field loss on health-related quality of life.

  1997cited by this paper
• Willingness-to-pay utility assessment: feasibility of use in normative patient decision support systems

  1997cited by this paper
• International applicability of the VF-14. An index of visual function in patients with cataracts.

  1997cited by this paper
• Levels of evidence and interventional ophthalmology.

  1997cited by this paper
• Are results of the SF-36 health survey and the Nottingham Health Profile similar? A comparison in COPD patients. Quality of Life in COPD Study Group.

  1997cited by this paper
• Visual function and quality of life among patients with glaucoma.

  1997cited by this paper
• Cost-Effectiveness of Screening for Carotid Stenosis in Asymptomatic Persons

  1997cited by this paper
• Recommendations of the Panel on Cost-effectiveness in Health and Medicine.

  1996cited by this paper
• Automated utility assessment of global health

  1996cited by this paper
• Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine.

  1996cited by this paper
• Cost Utility of the Multichannel Cochlear Implant in 258 Profoundly Deaf Individuals

  1996cited by this paper
• The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine.

  1996cited by this paper
• Evaluating health services: the importance of patients' preferences and quality of life.

  1995cited by this paper
• A clinician's guide to utility measurement.

  1995cited by this paper
• Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation.

  1995cited by this paper
• Perioperative imaging strategies for carotid endarterectomy. An analysis of morbidity and cost-effectiveness in symptomatic patients.

  1995cited by this paper
• Explaining Distortions in Utility Elicitation through the Rank-dependent Model for Risky Choices

  1995cited by this paper
• The VF-14. An index of functional impairment in patients with cataract.

  1994cited by this paper
• Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire.

  1994cited by this paper
• Cost utility analysis: what should be measured?

  1994cited by this paper
• Incorporating patients' preferences into medical decisions.

  1994cited by this paper
• Feasibility of utility assessment by rating scale and standard gamble in patients with ankylosing spondylitis or fibromyalgia.

  1994cited by this paper
• Markov Models in Medical Decision Making

  1993cited by this paper
• Cost-effectiveness of screening and cryotherapy for threshold retinopathy of prematurity.

  1993cited by this paper
• Relationship between psychometric and utility-based approaches to the measurement of health-related quality of life

  1993cited by this paper
• Methods for assessing relative importance in preference based outcome measures

  1993cited by this paper
• The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection

  1992cited by this paper
• How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.

  1992cited by this paper
• The MOS 36-Item Short-Form Health Survey (SF-36)

  1992cited by this paper
• Chemoprophylaxis of prosthetic joint patients during dental treatment: a decision-utility analysis.

  1991cited by this paper
• Quality-adjusted Life Years, Utility Theory, and Healthy-years Equivalents

  1989cited by this paper
• Methodology for measuring health-state preferences--II: Scaling methods.

  1989cited by this paper
• Utilities and Quality-Adjusted Life Years

  1989cited by this paper
• Utility approach to measuring health-related quality of life.

  1987cited by this paper
• Preferences for Health Outcomes

  1984cited by this paper
• Adding insult to injury. Usurping patients' prerogatives.

  1983cited by this paper
• New visual acuity charts for clinical research.

  1982cited by this paper
• Foundations of cost-effectiveness analysis for health and medical practices.

  1977cited by this paper

• The Visual Effectiveness and Cost‐Effectiveness of Vitrectomy and Membrane Peeling for Primary Idiopathic Epiretinal Membranes (iERMs): A Systematic Review

  2026cites this paper
• Impact of neurotrophic keratopathy on quality of life: a utility analysis.

  2025cites this paper
• Economics of corneal cross-linking for keratoconus treatment

  2025cites this paper
• Cost Effectiveness Analysis of Digital Therapeutics for Amblyopia.

  2025cites this paper
• Neural Network-Based Prediction of Post-Operative Visual Outcomes Following Secondary Pediatric Intraocular Lens Implantation

  2025cites this paper
• Nuances in visual rehabilitation after pituitary surgery

  2025cites this paper
• Economic Value of Enhanced Monofocal Intraocular Lenses for Cataract Surgery in Italy.

  2025cites this paper
• Economic Evaluation of Intraocular Lens Targeting Cataract Patients: A Review and Future Directions

  2025cites this paper
• The Freiburg Acuity Test in Preschool Children: Testability, Test–Retest Variability, and Comparison With LEA Symbols

  2024cites this paper
• Foveal neural adaptation to optically induced contrast reduction

  2024cites this paper
• Cost-Effectiveness Analysis of Fluocinolone Acetonide Intravitreal (FAI) Implant for Chronic Noninfectious Uveitis Affecting the Posterior Segment of the Eye (NIU-PS) in China

  2024influential citation
• Freiburg vision test (FrACT): optimal number of trials?

  2024cites this paper
• Estimating Australian Population Utilities for Inherited Retinal Disease Using Time Trade-Off

  2024influential citation
• Economic evaluations in cataract surgery: a narrative review

  2024influential citation
• Vécus et ressentis chez deux hommes receveurs d’une greffe de cornée

  2024cites this paper
• Training a high-performance retinal foundation model with half-the-data and 400 times less compute

  2024cites this paper
• Evaluation of dietary patterns and their impact on eye health among Saudi adults—A multi-regional cross-sectional analysis in Makkah, Riyadh, and Qassim

  2024cites this paper
• Costs and cost-effectiveness of the Kerala pilot screening programme for diabetic retinopathy in the public health system

  2024cites this paper
• Measuring Quality of Life in Diabetic Retinal Disease: A Narrative Review of Available Patient-Reported Outcome Measures

  2023influential citation
• Evaluating fine changes in visual function of diabetic eyes using spatial-sweep steady-state pattern electroretinography

  2023cites this paper
• Correlation between Health-Related Quality Of Life Scores and Measures of Visual Function in an Abuja Cohort of Primary Open Angle Glaucoma Patients

  2023cites this paper
• Association Between Longitudinal 10-2 Central Visual Field Change and the Risk of Visual Acuity Loss in Mild-to-Moderate Glaucoma

  2023cites this paper
• Eye Disease Prevalence and VF-14 Validation Among Patients Experiencing Homelessness and Presenting for Ophthalmic Examination in Baltimore, Maryland

  2023cites this paper
• Identification of loci involved in childhood visual acuity and associations with cognitive skills and educational attainment

  2023cites this paper
• Effect of Lens Status on Diabetic Vitreous Hemorrhage Resolution

  2023cites this paper
• Optical coherence tomography and optical coherence tomography angiography: essential tools for detecting glaucoma and disease progression

  2023influential citation
• A systematic review of economic evaluations for RPE65-mediated inherited retinal disease including HTA assessment of broader value

  2023cites this paper
• Recent evidence of economic evaluation of artificial intelligence in ophthalmology

  2023cites this paper
• Cost-Utility Analysis of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration.

  2023cites this paper
• Minimally Invasive Sub-Retinal Transplantation of RPE-J Cells on a Biodegradable Composite PCL/Collagen Nanosheet

  2023cites this paper
• More than meets the eye: the ocular toxicities accessory to anticancer therapies.

  2023cites this paper
• Complement inhibitors for age-related macular degeneration.

  2023cites this paper
• The Basic VRS-Effect Study: Clinical Trial Outcomes and Cost-Effectiveness of Low Vision Rehabilitation in Portugal

  2022cites this paper
• Association of macular OCT and OCTA parameters with visual acuity in glaucoma

  2022cites this paper
• Long-Term Burden of Pain and Reduced Visual Acuity after Gunshot Wounds to the Orbit

  2022cites this paper
• Comparison of the Cost-Effectiveness of SMILE, FS-LASIK, and PRK for Myopia in a Private Eye Center in Spain.

  2022cites this paper
• Preference-based comparison of the quality of life associated with vision loss in Black and White U.S. ophthalmic populations.

  2022cites this paper
• The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review

  2022cites this paper
• Quality of life associated with no light perception vision.

  2022cites this paper
• Cost-effectiveness of Artificial Intelligence-Based Retinopathy of Prematurity Screening.

  2022cites this paper
• Quality of Life in Craniopharyngioma: A Systematic Review.

  2022cites this paper
• Quality-adjusted life years in macular oedema due to age-related macular degeneration, diabetes and central retinal vein occlusion: the impact of anti-VEGF agents in a tertiary centre in Greece

  2022cites this paper
• Detection of multiple retinal diseases in ultra-widefield fundus images using deep learning: data-driven identification of relevant regions

  2022cites this paper
• Results of the basic-VRS trial: clinical outcomes and cost-effectiveness of basic low vision rehabilitation in Portugal

  2022cites this paper
• Cost‐effectiveness of dexamethasone and triamcinolone for the treatment of diabetic macular oedema in Finland: A Markov‐model

  2021cites this paper
• Economic appraisal of prosthetic replacement of ocular surface ecosystem in Canada.

  2021cites this paper
• Cost-Utility Analysis of Mycophenolate Mofetil versus Methotrexate for Noninfectious Uveitis.

  2021cites this paper
• Opportunities to Reduce Potential Bias in Ophthalmic Cost-Utility Analysis.

  2021cites this paper
• Neurophysiological considerations for visual implants

  2021cites this paper
• Challenges of cost-effectiveness analyses of novel therapeutics for Inherited Retinal Diseases: Cost-effectiveness analysis in Inherited Retinal Diseases.

  2021cites this paper
• Primary trabeculectomy versus primary glaucoma eye drops for newly diagnosed advanced glaucoma: TAGS RCT.

  2021cites this paper
• Multimodal imaging interpreted by graders to detect re-activation of diabetic eye disease in previously treated patients: the EMERALD diagnostic accuracy study.

  2021cites this paper
• Cost-effectiveness analysis of preloaded versus non-preloaded Descemet membrane endothelial keratoplasty for the treatment of Fuchs endothelial corneal dystrophy in an academic centre

  2021cites this paper
• Vision-related quality-of-life estimates in adolescent youths.

  2021cites this paper
• Value-based Medicine and Gene Therapy.

  2021cites this paper
• Cost-effectiveness analysis of ranibizumab for retinal vein occlusion patients in China from the societal perspective

  2021cites this paper
• Methodological Challenges in the Economic Evaluation of a Gene Therapy for RPE65-Mediated Inherited Retinal Disease: The Value of Vision

  2021cites this paper
• Vision-Related Quality of Life among Adult Patients with Visual Impairment at University of Gondar, Northwest Ethiopia

  2020cites this paper
• Cost-Effectiveness of Preoperative OCT in Cataract Evaluation for Multifocal Intraocular Lens.

  2020cites this paper
• Cost-Effectiveness

  2020cites this paper
• Responsibility for Funding Refractive Correction in Publicly Funded Health Care Systems: An Ethical Analysis

  2020cites this paper
• Intravitreal Use of a Bone Marrow Mononuclear Fraction (BMMF) Containing CD34+ Cells in Patients with Stargardt Type Macular Dystrophy

  2020cites this paper
• Dementia and Chronic Disease: Management of Comorbid Medical Conditions

  2020cites this paper
• Painting with the Eye: Understanding The Visual Field of the Human Eye with SSVEP

  2020cites this paper
• Cost-effectiveness of the triple procedure - phacovitrectomy with posterior capsulotomy compared to phacovitrectomy and sequential procedures.

  2020influential citation
• Visual impairment and ten-year mortality: the Liwan Eye Study

  2020cites this paper
• Visual Issues in Older Adults with Dementia

  2020cites this paper
• Vision-related Quality of Life among Adult Patients with Visual Impairment at a Tertiary Eye Centre, South-South Nigeria

  2020cites this paper
• Cost-Utility Analysis of VEGF-Inhibitors for Treating Neovascular Age-Related Macular Degeneration.

  2020cites this paper
• Visual Impairment Is More Common in Parkinson’s Disease and Is a Risk Factor for Poor Health Outcomes

  2020cites this paper
• Stem cell therapies for retinal diseases: from bench to bedside

  2020cites this paper
• Vision utilities in Italy and the United States: Comparison of time tradeoff vision utilities

  2020influential citation
• Interpreting the Visual Acuity of the Human Eye with Wearable EEG Device and SSVEP

  2020cites this paper
• Cost-Effectiveness of Preoperative Optical Coherence Tomography in Cataract Evaluation for Multifocal Intraocular Lens

  2020cites this paper
• Prevalence Of Ophthalmic Diseases, Drug Utilization And Vision Function Related Qol In Ophthalmic Patients At A Tertiary Care Hospital

  2020cites this paper
• Health economic evaluation in ophthalmology

  2020cites this paper
• Corneal cross-linking versus conventional management for keratoconus: a lifetime economic model

  2020cites this paper
• Self‐reported visual dysfunction in Parkinson disease: the Survey of Health, Ageing and Retirement in Europe

  2020cites this paper
• Prospective study to evaluate the effectivity and acceptance of optical low vision AIDS

  2019cites this paper
• Health Utility of Neovascular Age-Related Macular Degenerationat Mettapracharak (Wat Raikhing) Hospital

  2019cites this paper
• Adalimumab for non-infectious uveitis: is it cost-effective?

  2019cites this paper
• Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424).

  2019cites this paper
• Health care stakeholder perceptions of vision loss.

  2019cites this paper
• Blindness and Visual Impairment in the Medicare Population: Disparities and Association with Hip Fracture and Neuropsychiatric Outcomes

  2019cites this paper
• Cost Effectiveness of Limited Vitrectomy for Vision Degrading Myodesopsia.

  2019cites this paper
• Follow the nevus: the cost-utility of monitoring for growth of choroidal nevi.

  2019cites this paper
• A New Paradigm in the Treatment of Advanced Periocular Basal Cell Carcinoma?

  2019cites this paper
• Patient Preference-Based Comparative Effectiveness and Cost-Utility Analysis of the Prostamides for Open-Angle Glaucoma

  2019influential citation
• Potential lifetime quality of life benefits of choroideremia gene therapy: projections from a clinically informed decision model

  2019cites this paper
• Cost-Effectiveness Analysis of Descemet's Membrane Endothelial Keratoplasty Versus Descemet's Stripping Endothelial Keratoplasty in the United States.

  2019cites this paper
• Evaluation of Contrast Sensitivity after Four Different Treatment Modalities Using OPTEC-Functional Vision Analyzer in Primary Open-Angle Glaucoma

  2019cites this paper
• Dexamethasone implant for non-infectious uveitis: is it cost-effective?

  2019cites this paper
• The cost-effectiveness of bevacizumab, ranibizumab and aflibercept for the treatment of age-related macular degeneration—A cost-effectiveness analysis from a societal perspective

  2018cites this paper
• Social and economic impact of the commercialization of the Argus II artificial retina in the United States

  2018cites this paper
• Association of Genetic Variants With Response to Anti–Vascular Endothelial Growth Factor Therapy in Age-Related Macular Degeneration

  2018cites this paper
• Intravitreal Aflibercept Versus Ranibizumab for Wet Age-Related Macular Degeneration: A Cost-Effectiveness Analysis

  2018cites this paper
• In Reply: Seizure Outcomes in Occipital Lobe and Posterior Quadrant Epilepsy Surgery: A Systematic Review and Meta-Analysis.

  2018cites this paper
• Seizure Outcomes in Occipital Lobe and Posterior Quadrant Epilepsy Surgery: A Systematic Review and Meta-Analysis

  2018cites this paper
• Effects of L-carnitine supplementation on the quality of life in diabetic patients with muscle cramps.

  2018cites this paper
• Identifying the Underserved: An Analysis of a Free Eye Clinic’s Demographics

  2018cites this paper